Accord Logo

Intended for UK patients and members of the public

Argatroban Solution

Active Ingredients

Product Documentation

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Discontinued Other versions of this medicine may still be available. Information for reference purposes.

Argatroban 1 mg/ml solution for infusion

PL Number:
20075/0486
MA Holder:
Accord Healthcare Limited
Product Classification:
POM
Product Status:
Discontinued

Product Documentation

  • Description of update: Adaptation of the PI to reference product Novastan (SE/H/0483); furthermore editorial changes.

    SmPC Sections updated: 2, 4.2, 4.4, 4.5, 4.6, 4.8 and 10.

  • The following changes have been notified:

    A.5. b) The activities for which the manufacturer/importer is responsible do not include batch release

    • A.5. b) Change in the name of "Eurofins Analytical Services Hungary Kft." to "Eurofins BioPharma Product Testing Budapest Kft." as batch control/testing site. The address "Anonymus u 6., Budapest, 1045, Hungary" remains unchanged.

    • A.5. b) Change in the name of "Pharmavalid Ltd." to "Pharmavalid Kft." as batch control/testing site. The address "1136 Budapest, Tátra u. 27/b Hungary" remains unchanged.

    A.7. Deletion of manufacturing sites for an active substance, intermediate or finished product, packaging site, manufacturer responsible for batch release, site where batch control takes place, or supplier of a starting material, reagent or excipient (when mentioned in the dossier)*

    • A.7. Deletion of "Accord Healthcare B.V. Utrecht, Winthontlaan 200 3526 KV at Utrecht, The Netherlands" as batch release site.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

General FAQs

For any further assistance, please get in touch.

View product information as a: